Table 1.
Studies of intravenous thrombolytic therapy in acute ischemic stroke with ICA occlusion
Study | Treatment | Patients, n | Favorable outcome, definition | Favorable outcome, n (%) | Mortality, n (%) | sICH, n (%) |
---|---|---|---|---|---|---|
ICARO 17, 2012 | IV tPA within 4.5 h | 253 | mRS 0–2 at 3 mo. | 73 (29) | 65 (26) | 12 (5) |
ICARO-2 18, 2012 | IV tPA within 4.5 h | 134 | mRS 0–2 at 3 mo. | 43 (32.1) | 30 (22.4) | 8 (5.8) |
ICARO-3 26, 2015 | IV tPA within 4.5 h | 324 | mRS 0–2 at 3 mo. | 89 (27.4) | 75 (23.1) | n.a. |
EPITHET 16, 2010 | IV tPA within 6 h | 13 | mRS 0–2 at 3 mo. | 0 (0) | n.a. | n.a. |
CLOTBUST 22, 2007 | IV tPA within 3 h | 25 | mRS 0–2 at 3 mo. | 5 (20) | 7 (28) | 3 (12) |
Endo 3, 1998 | IV UK or tPA within 6 h | 12 | mRS 0–2 at 1 mo. | 0 (0) | 9 (75) | 0 (0) |
UK = Urokinase; mo = months; n.a. = not available.